Home › Researcher directory › Doaa Bugazia

Doaa Bugazia

Affiliation : University of Tripoli

• 2Publications (affiliation in Libya)
• 5Total publications
• 93Citations
• 3h-index

OpenAlex

Research profile

Doaa Bugazia has 2 indexed publications (2022). Their work appears mainly in “Current Oncology” and “Frontiers in Pharmacology”. Their most cited article, “Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series” (2022), has been cited 25 times.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• COVID-19 Clinical Research Studies
• SARS-CoV-2 and COVID-19 Research
• Pancreatic and Hepatic Oncology Research
• Systemic Lupus Erythematosus Research
• Hematopoietic Stem Cell Transplantation

Publications (2)

• Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
  2022 · Current Oncology · cited 25 times
• Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
  2022 · Frontiers in Pharmacology · cited 18 times

Publication venues

• Current Oncology × 1
• Frontiers in Pharmacology × 1

Bibliographic data from OpenAlex (open database).